Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ZILRETTA Versus CELESTONE in Knee Osteoarthritis
NCT05058209Phase 4Completed
- Sponsor
- ROC Foundation
- Start
- Nov 2020
- Primary completion
- Apr 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide in osteoarthritis (OA), sponsored by ROC Foundation. Started Nov 2020; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05058209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05058209.